Boehringer Ingelheim acquires Pharmaxis’ investigational drug PXS4728A
18 May 2015 | By Victoria White
Boehringer Ingelheim has acquired Pharmaxis’ investigational drug PXS4728A, to develop it for the treatment of NASH and to prevent its consequences...